Opus Genetics, Inc. — DEF 14A Filings
21 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Opus Genetics, Inc. (IRD), sorted by most recent first. Each row links to the full filing on EdgarLookup. Opus Genetics, Inc. has filed 21 DEF 14A documents with the SEC since 2003. To view all SEC filings by Opus Genetics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
10KSB
10QSB
144
25
3
4
4/A
424A
424B3
424B4
424B5
425
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTAMX
CORRESP
CT ORDER
D
DEF 14A
DEF 14C
DEFA14A
DEFC14A
DEFM14A
DEFR14A
DFAN14A
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRE 14C
PREC14A
PRER14A
PRER14C
PRRN14A
PX14A6G
REGDEX
S-3
S-3/A
S-4
S-4/A
S-8
SB-2
SB-2/A
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEF 14A | 0001140361-26-010757 | Mar 23, 2026 | Apr 20, 2026 |
| DEF 14A | DEF 14A | 0001140361-24-023004 | Apr 29, 2024 | Jun 11, 2024 |
| DEF 14A | DEF 14A | 0001140361-23-022044 | May 1, 2023 | Jun 6, 2023 |
| DEF 14A | DEF 14A | 0001140361-22-016115 | Apr 27, 2022 | Jun 13, 2022 |
| DEF 14A | DEF 14A | 0001140361-21-014256 | Apr 26, 2021 | Jun 7, 2021 |
| DEF 14A | DEF 14A | 0001140361-19-007856 | Apr 29, 2019 | Jun 6, 2019 |
| DEF 14A | DEF 14A | 0001140361-19-003255 | Feb 14, 2019 | Mar 26, 2019 |
| DEF 14A | DEF 14A | 0001140361-18-033155 | Jul 23, 2018 | Aug 30, 2018 |
| DEF 14A | DEF 14A | 0001140361-18-019246 | Apr 23, 2018 | Jun 14, 2018 |
| DEF 14A | REXAHN PHARMACEUTICALS INC. DEF 14A 4-11-2017 | 0001140361-17-009142 | Feb 24, 2017 | Apr 11, 2017 |
| DEF 14A | REXAHN PHARMACEUTICALS, INC. DEF 14A 6-9-2016 | 0001140361-16-061408 | Apr 18, 2016 | Jun 9, 2016 |
| DEF 14A | REXAHN PHARMACEUTICALS INC DEF14A 6-4-2015 | 0001140361-15-015351 | Apr 14, 2015 | Jun 4, 2015 |
| DEF 14A | REXAHN PHARMACEUTICALS, INC DEF 14A 6-9-2014 | 0001140361-14-017095 | Apr 18, 2014 | Jun 9, 2014 |
| DEF 14A | REXAHN PHARMACEUTICALS, INC DEF 14A 6-10-2013 | 0001140361-13-017009 | Apr 22, 2013 | Jun 10, 2013 |
| DEF 14A | REXAHN PHARMACEUTICALS INC DEF 14A 6-18-2012 | 0001140361-12-021555 | Apr 26, 2012 | Jun 18, 2012 |
| DEF 14A | REXAHN PHARMACEUTICALS, INC. DEF 14A 6-6-2011 | 0001140361-11-023216 | Apr 26, 2011 | Jun 6, 2011 |
| DEF 14A | REXAHN PHARMACEUTICALS DEF 14A 6-14-2010 | 0001140361-10-017500 | Apr 26, 2010 | Jun 14, 2010 |
| DEF 14A | REXAHN PHARMACEUTICALS, INC DEF 14A 6-1-2009 | 0001140361-09-009978 | Apr 20, 2009 | Jun 1, 2009 |
| DEF 14A | REXAHN PHARMACEUTICALS DEF14A 6-12-2008 | 0001140361-08-010435 | Apr 29, 2008 | Jun 12, 2008 |
| DEF 14A | REXAHN PHARMACEUTICALS, INC. DEF 14A 6-11-2007 | 0001140361-07-010103 | May 16, 2007 | Jun 11, 2007 |
| DEF 14A | REXAHN PHARMACEUTICALS DEF 14A 6-2-2006 | 0001140361-06-007441 | May 15, 2006 | Jun 2, 2006 |